Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Singh, Ahaana"'
Autor:
Singh, Ahaana1,2,3 (AUTHOR), Agongo, Godfred4 (AUTHOR), Chatio, Samuel T.1,5 (AUTHOR), Logonia, Bernard1 (AUTHOR), Debpuur, Cornelius Y.1,5,6 (AUTHOR), Ansah, Patrick O.1,5 (AUTHOR), Oduro, Abraham R.1,6 (AUTHOR), Klipstein-Grobusch, Kerstin7,8 (AUTHOR), Nonterah, Engelbert A.1,5,7 (AUTHOR) drenanonterah@gmail.com
Publikováno v:
BMC Primary Care. 6/26/2024, Vol. 25 Issue 1, p1-12. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Görgün G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. gullu_gorgun@dfci.harvard.edu kenneth_anderson@dfci.harvard.edu., Samur MK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Department of Biostatistics and Computational Biology, Harvard School of Public Health, Boston, Massachusetts., Cowens KB; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Paula S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Bianchi G; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Anderson JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., White RE; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Singh A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Ohguchi H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Suzuki R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Kikuchi S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Harada T; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Hideshima T; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Tai YT; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Laubach JP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Raje N; Massachusetts General Hospital, Boston, Massachusetts., Magrangeas F; Inserm UMR892, CNRS 6299, Université de Nantes, Nantes, France. Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France., Minvielle S; Inserm UMR892, CNRS 6299, Université de Nantes, Nantes, France. Centre Hospitalier Universitaire de Nantes, Unité Mixte de Genomique du Cancer, Nantes, France., Avet-Loiseau H; Unite de Genomique du Myelome, CHU Rangueil, Toulouse, France., Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Boston VA Health Care System, Boston, Massachusetts., Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. gullu_gorgun@dfci.harvard.edu kenneth_anderson@dfci.harvard.edu.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Oct 15; Vol. 21 (20), pp. 4607-18. Date of Electronic Publication: 2015 May 15.